“Blood Testing Market Report is set to have rapid growth due to constantly increasing geriatric population, advanced technological facilities and introduction of advanced technologies for the POC blood tests at global, regional and national level, influencing the industry trends in each of the sub-segments from 2019 to 2029”, says Visiongain Report

04 September 2019
Pharma

Visiongain has launched a new pharma report Blood Testing Market Forecast 2019-2029: By Test Type (Glucose, Lipid, BUN, A1C, CRP, Vitamin D, ALT, AST, Thyroid Stimulating Hormone), By Region, And Segment Forecasts

With increasing need for identification of infectious agents, cardiovascular diseases, cancer biomarkers, drug abuse, and women’s health issues blood testing market is expected to witness huge growth. A blood test can be used for various ailments like anaemia, infection, leukaemia, hypokalaemia, and kidney abnormalities besides cancer detection. Blood tests have also played great role in lab diagnosis, essential for treatment initiation.

Advancement in technologies have allowed blood testing to be precise, accurate requiring only a drop of blood to assess a biomarker instead of opting for a invasive process. Blood testing also allows for early diagnosis of a disease producing better health outcomes for a patient. Development in blood collecting procedures, analysers, sensors, automated blood testing with seamless transfer of information via digital therapeutics will see the blood testing market boom.

Leading companies featured in the report include Abbott Diagnostics, Bio-Rad Laboratories Inc, Roche Diagnostics, Quest Diagnostics, Biomerica, Inc, Siemens Healthineers (A Subsidiary of Siemens AG), Trinity Biotech PLC, Alere Inc, Beckman Coulter (A Subsidiary Of Danaher Corporation), Becton, Dickinson And Company.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

“Global Diagnostic Imaging market set to grow to $32bn by 2024” says Visiongain report

Diagnostic imaging technology such as MRI and CT scans has become more precise and accessible, due to which radiology has increasingly become a key foundation of modern medicine.

20 September 2019

Read

“Oncology remains the largest disease area in the pharmaceutical business. The oncology market is dominated by big pharma companies and high price labels” says Visiongain report

Although price is still the most important competitive advantage for a biosimilar company, current discount rates are not enough to automatically convince the key stakeholders of a biosimilar’s value.

10 September 2019

Read

“Anti-Infective Agents market set to grow to $141bn by 2024” says new Visiongain report

The global anti-infective agents market is one that is driven by innovation. This is vital for maintaining the rich pipeline of anti-infective agents seen in the market today.

09 September 2019

Read

“Global thyroid gland disorder treatment market is anticipated to grow at a lucrative CAGR of 3.6% and anticipated to reach USD 3.21 Billion by 2029”, says Visiongain report.

Thyroid disease is one of today’s most prevalent hormonal illnesses. Hyperthyroidism, hypothyroidism, and thyroid nodules are the most common thyroid gland disorders.

05 September 2019

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever
Do NOT follow this link or you will be banned from the site!